In tests using animals, drug successfully seeks and disarms toxic clumps of proteins responsible for Alzheimer’s and Parkinson’s
An international team of more than 18 research groups has demonstrated that the compounds they developed can safely prevent harmful protein aggregation in preliminary tests using animals. The findings raise hope that a new class of drugs may be on the horizon for the more than 30 diseases and conditions that involve protein aggregation, including diabetes, cancer, spinal cord injury, Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS).
Proteins are necessary for almost every cellular process. However, when cell machinery doesn’t clear out old proteins, they can clump, or aggregate, into toxic plaques that lead to disease.
“Diseases caused by protein aggregation affect millions of people around the world,” said Gal Bitan, Ph.D., associate professor of neurology at the David Geffen School of Medicine at the University of California – Los Angeles, who will present the team’s latest work at the American Society for Biochemistry and Molecular Biology (ASBMB) Annual Meeting during Experimental Biology 2015. “We hope that the new compounds will provide therapy for diseases caused by protein aggregation, many of which have no treatment at all.”
The researchers call the compounds that they developed molecular tweezers because of the way they wrap around the lysine amino acid chains that make up most proteins. The compounds are unique in their ability to attack only aggregated proteins, leaving healthy proteins alone.
To develop a new drug, researchers typically screen large libraries of compounds to find ones that affect a protein involved in a disease. Bitan’s team used a fundamentally different approach to develop the molecular tweezers.
“We looked at the molecular and atomic interactions of proteins to understand what leads to their abnormal clumping,” Bitan said. “Then, we developed a tailored solution. So unlike many other drugs, we understand how and why our drug works.”
The team is in the process of testing multiple versions of the tweezers, each with a slightly different molecular makeup. For CLR01, one of the most promising versions, the researchers have demonstrated therapeutic benefits in two rodent models of Alzheimer’s disease, two fish and one mouse model of Parkinson’s disease, a fish model of spinal cord injury and a mouse model of familial amyloidotic polyneuropathy, a rare disease in which protein aggregation affects the nervous system, heart and kidneys.
“Our data suggest that CLR01, or a derivative thereof, may become a drug for a number of diseases that involve protein aggregation,” Bitan said. “We also found a high safety window for CLR01.”
In one of the safety tests, mice receiving a daily CLR01 dose 250 times higher than the therapeutic dose for one month showed no behavioral or physiological signs of distress or damage. In fact, blood cholesterol in the mice dropped by 40 percent, a possible positive side effect of CLR01.
The Latest on: Molecular tweezers
via Google News
The Latest on: Molecular tweezers
- Transformative Technology: To Understand Biology, Scientists Turn to the Quantum Worldon November 30, 2021 at 4:16 am
Researchers hope sensors using quantum tech could transform biology research. Scientists discovered nuclear magnetic resonance, a physical phenomenon where nuclei absorb and re-emit energy when placed ...
- Research snippetson November 25, 2021 at 4:00 pm
The network investigates molecular mechanisms at contact points between cells that regulate cell differentiation as well as the development and function of tissues.
- Spectrochimica acta. Part A, Molecular and biomolecular spectroscopyon November 23, 2021 at 4:01 pm
Interaction between olanzapine and human serum albumin and effect of metal ions, caffeine and flavonoids on the binding: A spectroscopic study. Construct a lysosome-targeting and highly selective ...
- LUMICKS Announces New Additions to its Executive Management Teamon November 17, 2021 at 7:42 am
LUMICKS, a next generation life science tools company, today announced it has added two new executives who will bring breadth and global ...
- High cell membrane tension constrains the spread of canceron November 8, 2021 at 6:17 am
Optical tweezers: Optical tweezers are concentrated ... Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Kobe, Hyogo 650-0017, Japan.
- Science and Technology Center for Engineering Mechano-Biologyon November 1, 2021 at 5:00 pm
The mission of this Center is to discover the governing principles of molecular and cellular communication, provide the intellectual foundations and materials for engineering new and powerful ...
- What Is Nanotechnologyon October 30, 2021 at 10:44 am
Some definitions include a reference to molecular nanotechnology and 'purists' argue that ... Besides cantilever-based instruments like the AFM, examples include optical tweezers, and magnetic pullers ...
- ACS Sensorson October 27, 2021 at 5:00 pm
Blending experts from molecular genetics, chemistry and health sciences, researchers at the University of California San Diego have created a rapid diagnostic technology that detects SARS-CoV-2 ...
- Fingerprinting proteins with forceon October 21, 2021 at 8:23 am
“Optical tweezers have been around for decades and ... “This research integrates molecular biophysics with cutting-edge DNA nanotechonlogy pioneered here at the Wyss Institute to allow us ...
via Bing News